An electronic mapping platform for a full view of the human genome
High resolution structural variant analysis
Delve into the realm of high-definition genome mapping and revolutionize your research with the Nabsys SV Discovery Grant. If chosen to win, you will receive free OhmX genome mapping for your research to further human health. Go to Resources >> SV Discovery Grant to apply.
The OhmX Analyzer is a simple benchtop solution designed to drive SV detection at the whole genome level. With its low cost and minimal set-up requirements, researchers and scientists can now conveniently access SV data, without compromising on sensitivity and accuracy.
Our state-of-the-art, electronic nanodetectors deliver the highest resolution for whole genome structural variant analysis. With the OhmX platform, you can perform whole genome analysis of SVs down to 300bp- enabling insights into previously undetectable DNA variations.
Nabsys has partnered with Hitachi High Tech to develop Human Chromosome Explorer™, a suite of secondary analytical software tools that seamlessly assembles genomes and identifies SVs according to custom parameters. Human Chromosome Explorer puts actionable SV data at your fingertips.
OhmX enables a variety of different SV analyses based on research needs ensuring a more complete view of the human genome.
A low cost instrument that fits on a standard benchtop and is easy to install in any laboratory.
High Definition Mapping DNA Preparation Kits have been validated for high molecular weight DNA isolated from blood and cell lines.
High Definition Mapping Nano-detectors can be reused to analyze multiple samples and minimize run costs.
High Definition Mapping Nano-detectors can be reused to analyze multiple samples and minimize run costs.
provides results in the cloud and accessible securely from anywhere powered by Hitachi.
60 Clifford Street
Providence, Rhode Island
02903 USA
Phone: 401.276.9100
Fax: 401.276.9122
info@nabsys.com
Advance the understanding of disease, increase diagnostic yield, and improve patient outcomes by enabling routine, accurate, cost-effective analysis of genomic structural variation